Radiological follow-up of osteonecrosis lesions in children and adolescents with Hodgkin lymphoma.

Autor: Aarnivala H; Department of Pediatrics, Oulu University Hospital, Oulu, Finland.; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland., Giertz M; Department of Pediatric Oncology and Hematology, Uppsala University Hospital, Uppsala, Sweden.; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden., Michelsen SW; Department of Pediatric and Adolescence Medicine, Clinic for Pediatric Oncology and Hematology, University Hospital Rigshospitalet, Copenhagen, Denmark., Björklund C; Department of Pediatric Hematology and Oncology, Umeå University Hospital, Umeå, Sweden., Englund A; Department of Pediatric Oncology and Hematology, Uppsala University Hospital, Uppsala, Sweden.; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden., Grönroos M; Department of Pediatrics, Turku University Hospital, Turku, Finland., Hjalgrim LL; Department of Pediatric and Adolescence Medicine, Clinic for Pediatric Oncology and Hematology, University Hospital Rigshospitalet, Copenhagen, Denmark., Huttunen P; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, New Children's Hospital, Helsinki University Hospital, Helsinki, Finland., Niinimäki T; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.; Department of Surgery, Oulu University Hospital, Oulu, Finland., Penno E; Department of Diagnostic Radiology, Uppsala University Hospital, Uppsala, Sweden., Pokka T; Research Service Unit, Oulu University Hospital, Oulu, Finland., Pöyhönen T; Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland., Raittinen P; Centre for Child Health Research, Tampere University and University Hospital, Tampere, Finland., Ranta S; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden., Svahn JE; Department of Pediatric Oncology, Skåne University Hospital, Lund University, Lund, Sweden., Törnudd L; Department of Pediatrics, Linköping University Hospital, Linköping, Sweden., Harila A; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden., Niinimäki R; Department of Pediatrics, Oulu University Hospital, Oulu, Finland.; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.

Publikováno v: British journal of haematology [Br J Haematol] 2024 Oct; Vol. 205 (4), pp. 1460-1468. Date of Electronic Publication: 2024 Aug 03.

Immune or inherited thrombocytopenia? A population-based cohort study on children and adolescents presenting with a low platelet count.

Autor: Kulmala LM; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland., Aarnivala H; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.; Department of Children and Adolescents, Oulu University Hospital, Oulu, Finland., Pokka T; Research Service Unit, Oulu University Hospital, Oulu, Finland., Huurre A; Department of Pediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland., Järvelä L; Department of Pediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland., Palmu S; Department of Pediatrics, Tampere University Hospital, and Tampere University, Faculty of Medicine and Health Technology, Center for Child, Adolescent and Maternal Health Research, Tampere, Finland., Pöyhönen T; Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland., Niinimäki R; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.; Department of Children and Adolescents, Oulu University Hospital, Oulu, Finland.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Dec; Vol. 71 (12), pp. e31363. Date of Electronic Publication: 2024 Oct 04.

Previous cancers in women diagnosed with premature ovarian insufficiency: A nationwide population-based case-control study.

Autor: Silvén H; Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, Oulu, Finland.; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.; Medical Research Center, University of Oulu and Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, Oulu, Finland., Savukoski SM; Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, Oulu, Finland.; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.; Medical Research Center, University of Oulu and Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, Oulu, Finland., Pesonen P; Infrastructure for Population Studies, Faculty of Medicine, University of Oulu, Oulu, Finland., Niinimäki R; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.; Medical Research Center, University of Oulu and Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, Oulu, Finland.; Department of Pediatrics, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, Oulu, Finland., Pukkala E; Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.; Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland., Gissler M; Department of Knowledge Brokers, THL Finnish Institute for Health and Welfare, Helsinki, Finland.; Academic Primary Health Care Center, Region Stockholm, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Suvanto E; Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, Oulu, Finland.; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.; Medical Research Center, University of Oulu and Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, Oulu, Finland., Niinimäki M; Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, Oulu, Finland.; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.; Medical Research Center, University of Oulu and Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, Oulu, Finland.

Publikováno v: Acta obstetricia et gynecologica Scandinavica [Acta Obstet Gynecol Scand] 2024 May; Vol. 103 (5), pp. 842-849. Date of Electronic Publication: 2024 Jan 27.

DNA polymerase gamma variants and hepatotoxicity during maintenance therapy of childhood acute lymphoblastic leukemia: is there a causal relationship?

Autor: Harju T; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland. tekla.harju@oulu.fi.; Department of Children and Adolescents, Oulu University Hospital, Oulu, Finland. tekla.harju@oulu.fi., Hurme-Niiranen A; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.; Medical Research Center, University of Oulu and Oulu University Hospital, Oulu, Finland., Suo-Palosaari M; Department of Diagnostic Radiology, Oulu University Hospital, Oulu, Finland.; Research Unit of Health Sciences and Technology, Oulu University Hospital and University of Oulu, Oulu, Finland., Nygaard Nielsen S; Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen University Hospital, and Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Hinttala R; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.; Medical Research Center, University of Oulu and Oulu University Hospital, Oulu, Finland.; Biocenter Oulu, University of Oulu, Oulu, Finland., Schmiegelow K; Pediatric Oncology Laboratory, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Uusimaa J; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.; Department of Children and Adolescents, Oulu University Hospital, Oulu, Finland.; Medical Research Center, University of Oulu and Oulu University Hospital, Oulu, Finland., Harila A; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden., Niinimäki R; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.; Department of Children and Adolescents, Oulu University Hospital, Oulu, Finland.

Publikováno v: The pharmacogenomics journal [Pharmacogenomics J] 2023 Sep; Vol. 23 (5), pp. 105-111. Date of Electronic Publication: 2023 May 03.

The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia.

Autor: Hakkarainen M; Applied Tumor Genomics Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland.; Department of Medical and Clinical Genetics/Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Kaaja I; Applied Tumor Genomics Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Medical and Clinical Genetics/Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Douglas SPM; Applied Tumor Genomics Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Medical and Clinical Genetics/Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Vulliamy T; Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Dokal I; Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London and Barts Health, London, United Kingdom., Soulier J; Hematology Laboratory and INSERM U944, Saint-Louis Hospital, University of Paris, Paris, France., Larcher L; Hematology Laboratory and INSERM U944, Saint-Louis Hospital, University of Paris, Paris, France., Peffault de Latour R; French Reference Center for Aplastic Anemia, BMT unit, Saint-Louis Hospital, Paris Cité University, Paris, France., Leblanc T; Department of Immunology and Pediatric Hematology, Assistance Publique-Hôpitaux de Paris, Robert Debré Hospital, URP3518 University Paris Cité, Paris, France., Sicre de Fontbrune F; French Reference Center for Aplastic Anemia, BMT unit, Saint-Louis Hospital, Paris Cité University, Paris, France., Siitonen T; Department of Medicine, Oulu University Hospital Cancer Center, Oulu, Finland., Lohi O; Tampere Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland., Hellström-Lindberg E; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Huddinge, Sweden.; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Barbany G; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden., Tesi B; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Huddinge, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden., Shimamura A; Dana-Farber/Boston Children's Hospital Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA., Beier F; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, RWTH Aachen University, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Aachen, Germany., Jackson S; Department of Haematology, Te Whatu Ora Health New Zealand Counties Manukau, Auckland, New Zealand., Kuperman AA; Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.; Blood Coagulation Service and Pediatric Hematology Clinic, Galilee Medical Center, Nahariya, Israel., Falik Zaccai T; Blood Coagulation Service and Pediatric Hematology Clinic, Galilee Medical Center, Nahariya, Israel., Tamary H; The Rina Zaizov Hematology-Oncology Division, Schneider Children's Medical Center of Israel, Petah Tikva, Israel., Mecucci C; Laboratorio di Citogenetica e Medicina Molecolare, Sezione di Ematologia ed Immunologia Clinica, Centro Ricerche Emato-Oncologiche, Università degli Studi di Perugia, Perugia, Italy., Capolsini I; Pediatric Oncohematology with Bone Marrow Transplant, S. Maria della Misericordia Hospital, Perugia, Italy., Jahnukainen K; Children's Hospital, and Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Salmenniemi U; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland., Niinimäki R; Department of Pediatrics, Oulu University Hospital and PEDEGO Research Unit, University of Oulu, Oulu, Finland., Varilo T; Department of Medical and Clinical Genetics/Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland., Kilpivaara O; Applied Tumor Genomics Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Medical and Clinical Genetics/Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; HUS Diagnostic Center (Helsinki University Hospital), HUSLAB Laboratory of Genetics, University of Helsinki, Helsinki, Finland., Wartiovaara-Kautto U; Applied Tumor Genomics Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland.

Publikováno v: Blood [Blood] 2023 Jun 08; Vol. 141 (23), pp. 2853-2866.